APA

Nimmrich I., Sieuwerts A. M., Meijer-van Gelder M. E., Schwope I., Bolt-de Vries J., Harbeck N., Koenig T., Hartmann O., Kluth A., Dietrich D., Magdolen V., Portengen H., Look M. P., Klijn J. G. M., Lesche R., Schmitt M., Maier S., Foekens J. A. & Martens J. W. M. (20081113). DNA hypermethylation of PITX2 is a marker of poor prognosis in untreated lymph node-negative hormone receptor-positive breast cancer patients. : Breast cancer research and treatment.

Chicago

Nimmrich Inko, Sieuwerts Anieta M, Meijer-van Gelder Marion E, Schwope Ina, Bolt-de Vries Joan, Harbeck Nadia, Koenig Thomas, Hartmann Oliver, Kluth Antje, Dietrich Dimo, Magdolen Viktor, Portengen Henk, Look Maxime P, Klijn Jan G M, Lesche Ralf, Schmitt Manfred, Maier Sabine, Foekens John A and Martens John W M. 20081113. DNA hypermethylation of PITX2 is a marker of poor prognosis in untreated lymph node-negative hormone receptor-positive breast cancer patients. : Breast cancer research and treatment.

Harvard

Nimmrich I., Sieuwerts A. M., Meijer-van Gelder M. E., Schwope I., Bolt-de Vries J., Harbeck N., Koenig T., Hartmann O., Kluth A., Dietrich D., Magdolen V., Portengen H., Look M. P., Klijn J. G. M., Lesche R., Schmitt M., Maier S., Foekens J. A. and Martens J. W. M. (20081113). DNA hypermethylation of PITX2 is a marker of poor prognosis in untreated lymph node-negative hormone receptor-positive breast cancer patients. : Breast cancer research and treatment.

MLA

Nimmrich Inko, Sieuwerts Anieta M, Meijer-van Gelder Marion E, Schwope Ina, Bolt-de Vries Joan, Harbeck Nadia, Koenig Thomas, Hartmann Oliver, Kluth Antje, Dietrich Dimo, Magdolen Viktor, Portengen Henk, Look Maxime P, Klijn Jan G M, Lesche Ralf, Schmitt Manfred, Maier Sabine, Foekens John A and Martens John W M. DNA hypermethylation of PITX2 is a marker of poor prognosis in untreated lymph node-negative hormone receptor-positive breast cancer patients. : Breast cancer research and treatment. 20081113.